News tagged with national institute

Blincyto approved for rare leukemia

(HealthDay)—Blincyto (blinatumomab) has been approved by the U.S. Food and Drug Administration to treat Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia, a rare cancer of the bone marrow.

Dec 03, 2014
popularity not rated yet | comments 0

University of Chicago to establish Genomic Data Commons

The University of Chicago is collaborating with the National Cancer Institute to establish the nation's most comprehensive computational facility that stores and harmonizes cancer genomic data generated through NCI-funded ...

Dec 02, 2014
popularity not rated yet | comments 0